The Pharma Summit 2012 will be organized at London, United Kingdom on 9 February 2012.
Commemorating its 18th year, this annual Summit identifies those trends that have the potential to truly transform the pharmaceutical industry. This Pharma summit will bring together leading thinkers and experts, who will present a fresh perspective.
With 4 weeks to go we have an excellent speaker line up including:
- Simon Dingemans, Chief Financial Officer Designate, GlaxoSmithKline
- Anders Ekblom, Executive Vice-president, Global Drug Development, AstraZeneca
- Sir Andrew Dillon, Chief Executive, National Institute for Health and Clinical Excellence
- Tachi Yamada, Chief Medical and Scientific Officer, Executive Vice-president and Board Member, Takeda Pharmaceuticals
- Dr John Pottage, Chief Scientific and Medical Officer, ViiV Healthcare
- Brian Griffin, Chief Executive Officer, Medco International
- Theresa Heggie, Senior Vice-president, Global Commercial Operations, Shire HGT
- Bruno Strigini, President, Europe/Canada, Merck
More than 100 senior executives from the Pharma industry have already registered for this conference including 8 of the world’s top 10 pharmaceutical companies. Moreover, 80% of the audience is director level or above.
For further information, visit the link.
